Given Imaging

Motus GI Announces Appointment of Ravit Ram as Chief Financial Officer

Retrieved on: 
Monday, June 5, 2023
Gastrointestinal tract, Given Imaging, Boston Scientific, Controller, Site manager, U.S. FDA, Medtronic, CFO, FDA, Ravit Helled, Management, Motus

This appointment completes the Company’s reorganization, in-line with its strategic focus announced in April 2023.

Key Points: 
  • This appointment completes the Company’s reorganization, in-line with its strategic focus announced in April 2023.
  • He was instrumental in supporting our strategic initiatives and overseeing all aspects of our financial strategy over the past six years.
  • Ms. Ram brings more than 20 years of experience in leading financial and operational organizations of global technology and medical devices companies.
  • Most recently, she served as a senior member of the Motus GI management team, including as Site Manager, and VP of Global Operation and Finance, since 2018.

Gynesonics Names Industry Veteran Skip Baldino President and CEO, Announces $25M Financing to Expand Worldwide Commercialization

Retrieved on: 
Tuesday, April 11, 2023
Transoral incisionless fundoplication, Given Imaging, Abbott, Abbott Laboratories, Woman, Sale, Regenerative medicine, Calumet Specialty Products Partners, GERD, ACell, Uterine fibroid, Hospital Productions, Growth, Gastroesophageal reflux disease, Hospira, Health, EGS, Covidien, Pharmaceutical industry, Nursing

Mr. Baldino, who will also serve as member of the Board of Directors, succeeds Christopher Owens.

Key Points: 
  • Mr. Baldino, who will also serve as member of the Board of Directors, succeeds Christopher Owens.
  • Gynesonics is also pleased to announce that the company has closed on a significant financing of $25M to help further drive the growth and adoption of the Sonata® System.
  • Mr. Baldino has over 35 years of healthcare experience in both private start-ups and large public companies.
  • “I am excited to join the Gynesonics team at this pivotal point in the company’s commercial evolution,” said Mr. Baldino.

IsoPlexis Announces the Appointment of former Luminex Corporation Chairman and CEO, Nachum “Homi” Shamir to its Board of Directors

Retrieved on: 
Tuesday, August 23, 2022
COVID-19, HIV disease progression rates, Security (finance), Proteome, Compensation, The Scientist (magazine), Sale, Board, Â, Forward-looking statement, SEC, Cell, U.S. Securities and Exchange Commission, Housing, Communities and Local Government Committee, Nahum, Given Imaging, Isoplexis, Luminex Corporation, GLOBE, Board of directors, Nasdaq, CCTS, Regulation, Medtronic, DiaSorin, Director, Private Securities Litigation Reform Act, Industry, Health, Growth, Management, Pharmaceutical industry, Risk management, Fierce, Covidien

Mr. Shamir was most recently the Chairman and Chief Executive Officer of Luminex Corporation from 2014 through its sale to DiaSorin S.p.A. in 2021.

Key Points: 
  • Mr. Shamir was most recently the Chairman and Chief Executive Officer of Luminex Corporation from 2014 through its sale to DiaSorin S.p.A. in 2021.
  • Mr. Shamir currently serves on the Board of Directors of Strata Skin Sciences (Nasdaq: SSKN); and as Chairman of the Boards of Mediwound (Nasdaq: MDWD) and Cactus Acquisition Corp. (Nasdaq: CCTS).
  • On behalf of IsoPlexis's shareholders and Board, I would like to welcome Homi to our Board.
  • IsoPlexis has been named Top Innovation or Design by The Scientist Magazine, Fierce, BIG Innovation, Red Dot and multiple others.

Makana Therapeutics Announces the Appointment of Dr. Kurt Dasse to Its Board of Directors

Retrieved on: 
Wednesday, August 11, 2021
United States Air Force Scientific Advisory Board, ASAIO, Therapy, National, International Society, Patient, Pulmonary hypertension, Physiology, Tissue, Lung, Inspiration, Cell, Given Imaging, TCI, Company, Animal, Artio, Thoratec, Adult, Organ transplantation, Goal, Thermo Electron, Board, CH, Tufts University School of Medicine, Nitric oxide, Health, CEO, Miniature pig, Battelle Memorial Institute, Boston University, Abbott Laboratories, Hypothermia, Biological engineering, Ventricular assist device, Gene editing, Genetics, Kidney, Research, LLC, University, Board of directors, Medical device, Management, Pharmaceutical industry

Kurt Dasseas a new director to theMakana Therapeutics'board and especially value thedialoguewe have hadthus far.Dr.

Key Points: 
  • Kurt Dasseas a new director to theMakana Therapeutics'board and especially value thedialoguewe have hadthus far.Dr.
  • Dr. Dasse replaces Dr. Cathy Thut, who stepped down from the Makana Therapeutics Board to pursue a new opportunity in thebiotechmarket.
  • "We appreciate Cathy'scollaborativeapproach and are pleased to have worked together to enhance the company'sposition," said Joe Tector, MD, Ph.D.,Founderat Makana Therapeutics.
  • Under the scientific leadership of Dr.Joe Tector,Makana Therapeutics has achievedthe world's mostcompelling pre-clinical results in the field of xenotransplantation.

CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19

Retrieved on: 
Wednesday, September 23, 2020
Clinical medicine, Medicine, Medical specialties, Diagnostic gastroenterology, Capsule endoscopy, Endoscopy, Gastrointestinal tract, Enteroscopy, Given Imaging

The labeling addendum permits a fully remote capsule endoscopy procedure for eligible patients, eliminating the need for in-person interaction between clinic staff and patient.

Key Points: 
  • The labeling addendum permits a fully remote capsule endoscopy procedure for eligible patients, eliminating the need for in-person interaction between clinic staff and patient.
  • "CapsoVision's advanced capsule technology delivers high-quality diagnostic images without creating a risk of in-person exposure to COVID-19," stated Johnny Wang, President and CTO.
  • The CapsoCam Plus video capsule system is intended for the visualization of the small bowel mucosa in adults.
  • CapsoVision currently offers the CapsoCam Plus capsule endoscopy system in over 70 countries, and CapsoCloud and CapsoPro services in the USA.

United States Capsule Endoscopy Market 2019-2025: Focus on Camera Capsule, Workstation, & Data Recorder Market

Retrieved on: 
Thursday, March 28, 2019
Medicine, Clinical medicine, Diagnostic gastroenterology, Health, Endoscopy, Gastroenterology, Given Imaging, Capsule endoscopy, Yokneam, Capsule

DUBLIN, March 28, 2019 /PRNewswire/ -- The "Capsule Endoscopy Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 28, 2019 /PRNewswire/ -- The "Capsule Endoscopy Market Report - United States - 2019-2025" report has been added to ResearchAndMarkets.com's offering.
  • Prices are expected to remain stable, as this is a highly concentrated market with few players and a clear market leader.
  • Overall, the capsule endoscopy market is expected to grow steady at a single-digit rate over the forecast period.
  • Capsule endoscopy was first introduced in the U.S. in 2001 by Given Imaging, an Israeli company based in Yokneam, Israel.